Fruite XB (Calcium Fructoborate)
Fruite XB (Calcium Fructoborate) is a naturally occurring boron-based mineral complex that is found in fruits and vegetables. It is commercially marketed as FruiteX-B® Brand calcium fructoborate (FrXB). The commercially produced FrXB calcium fructoborate complex is formed by a proprietary reaction.
Benefits of Fruite XB (Calcium Fructoborate)
Fruite XB (Calcium Fructoborate) has been shown to provide fast-acting joint and flex support in as little as 7 days. It also provides long-lasting joint comfort. A double-blind, placebo-controlled study evaluated the effect of CF on systemic inflammation and dyslipidemia markers for middle-aged people. The study found that calcium fructoborate significantly reduced C-reactive protein levels, total cholesterol, low-density lipoprotein, triglycerides, IL-1β, IL-6, and MCP-1.
Another study showed that Fruite XB supplementation for 30 days significantly improved best drive distance more than placebo. A 90-day double-blind placebo-controlled randomized clinical study showed that once-daily and twice-daily dosing of calcium fructoborate improved knee discomfort. WOMAC and McGill results indicated that subjects in the FruiteX-B group experienced significant improvements in pain, stiffness, and physical function compared to the placebo group.
The recommended dosage of Fruite XB (Calcium Fructoborate) varies depending on the product. However, a typical dose is 108 mg per day. Like any supplement, Fruite XB (Calcium Fructoborate) can cause side effects in some individuals. The most common side effects include digestive upset, headaches, and dizziness. However, these side effects are generally mild and go away on their own.
Sources:
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930945/
- https://www.futureceuticals.com/fruitex-b
- https://www.tandfonline.com/doi/full/10.1186/s12970-014-0065-4
- https://www.researchgate.net/publication/326069243
- https://www.nutraingredients.com/Article/2012/02/22/Calcium-fructoborate-shows-promise-in-knee-osteoarthritis-pilot-study
